Joyce Kan

Joyce Kan is an accomplished Associate Scientist at adMare BioInnovations since August 2021, specializing in bio-analytical support for small molecules and biologics therapeutic programs. With a robust background involving assay development and pharmacokinetic evaluations, Joyce has held key roles, including Research Scientist at BRI Biopharmaceutical Research Inc, where bio-analytical projects were managed in compliance with GLP regulations. Previous experience includes positions at Maxxam Analytics, Celator Pharmaceuticals, and Cantest, focusing on method development, product stability testing, and regulatory submissions. Joyce Kan earned a BSc. Hons in Biochemistry from The University of British Columbia in 2001.